>
<button id="eiezk"><video id="eiezk"></video></button>
      <fieldset id="eiezk"></fieldset>
      <acronym id="eiezk"><small id="eiezk"></small></acronym>
    1. <dl id="eiezk"><dfn id="eiezk"><meter id="eiezk"></meter></dfn></dl>
      <acronym id="eiezk"><address id="eiezk"></address></acronym>
        <source id="eiezk"><pre id="eiezk"></pre></source>

        新wu應(yīng)力旋轉(zhuǎn)微重力培養(yǎng)

        型號:BAM
        聯(lián)系人:李先生
        聯(lián)系電話:18618101725
        品牌:美國

        新wu應(yīng)力旋轉(zhuǎn)微重力培養(yǎng)

        生物反應(yīng)器點


        1)該生物反應(yīng)器可以打開,而RCCS生物反應(yīng)器不可以。


        此特點可使實驗人員隨時收集或處理樣本。例如,可用藥物處理3D組織,然后研究其對擬組織的效應(yīng)和恢復(fù)情況。


        2)體積固定(10 mL)。


        RCCS生物反應(yīng)器配備了可拉伸硅膠膜,灌注體積高達12 mL。在細胞培養(yǎng)過程中,水分會從膜內(nèi)蒸發(fā),在出現(xiàn)明顯氣泡前體積可降至8 mL。此時培養(yǎng)基離子強度會顯著增加,擬組織內(nèi)的細胞會受到脅迫。生物反應(yīng)器采用了剛性膜,體積為10 mL,不會發(fā)生這種情況。


        3)生物反應(yīng)器側(cè)面帶有端口,便于更換培養(yǎng)基和除氣泡。

        4)生物反應(yīng)器內(nèi)置水合腔和加室通路。
        此特點可使其置于干燥的孵箱內(nèi)使用,減少細菌和支原體污染。在長期培養(yǎng)時這點尤其重要(有的實驗培養(yǎng)時間超過300天)。RCCS沒有水合腔。

        BAM單元點


        1)BAM有16個立驅(qū)動


        驅(qū)動單元冷卻在37?C以免影響孵箱溫度。RCCS系統(tǒng)4個驅(qū)動。如果要在同一個孵箱內(nèi)使用兩個單元,需要購買一個能夠冷卻和加熱的孵箱。目前尚沒有能夠同時冷卻四個RCCS單元的孵箱。如果要同時進行16個培養(yǎng),需要購買另外的可冷卻孵箱。


        2)BAM由平板電腦wu線控制
        戴上手套可很方便地調(diào)節(jié)速度和清理表面。RCCS則是采用了一個帶電位計的控制盒。


        3)BAM轉(zhuǎn)動非常平滑
         BAM旋轉(zhuǎn)時的抖動顯著減少,因此轉(zhuǎn)速低時也可以使用。


        4)顯示器顯示的是驅(qū)動單元馬達軸的真實轉(zhuǎn)速

        RCCS顯示的是設(shè)定的轉(zhuǎn)速,真實轉(zhuǎn)速可能不同。
        5)通過W-LAN通訊和安卓界面進行控制
        RCCS系統(tǒng)是電子/機械式的。 BAM帶有18個微電腦(不含平板電腦)。


        6)BAM帶有日志系統(tǒng)
        時間和驅(qū)動桿設(shè)置變化都記錄在一個只讀存儲器中(用戶不能改變記錄)。這種功能可以用于產(chǎn)生績效文件(如用于制藥工業(yè)中的藥物開發(fā))。RCCS沒有此特點。

        文獻:


        Publications
        1. Metabolic Reprogramming and the Recovery of Physiological Functionality in 3D Cultures in Micro-Bioreactors
          Krzysztof Wrzesinski and Stephen J. Fey
          Bioengineering, 5 (2) 1-25: 2018
          DOI: 10.3390/bioengineering5010022

        2.  
        3. Recent advances in three-dimensional cell culturing to assess liver function and dysfunction: from a drug biotransformation and toxicity perspective.
          Carlemi Calitz, Josias H. Hamman, Stephen J. Fey, Krzysztof Wrzesinski & Chrisna Gouws
          Toxicology Mechanisms and Methods, 2018
        4. Acetaminophen-induced S-nitrosylation and S-sulfenylation signalling in 3D cultured hepatocarcinoma cell spheroids.
          K. Wojdyla, K. Wrzesinski, J. Williamson, P. Roepstorff, S.J. Fey, A. Rogowska-Wrzesinska 
          Toxicology Research 5(2) 905-920, 2016 
        5. From 2D to 3D - a new dimension for modelling the effect of natural products on human tissue. 
          K. Wrzesinski and S.J. Fey
          Current Pharmaceutical Design 21(38): 5605-5616, 2015. 
          PMID: 26429710 
          DOI: 10.2174/1381612821666151002114227
        6. Top-down and Middle-down Protein Analysis Reveals that Intact and Clipped Human Histones Differ in Post-translational Modification Patterns. 
          A. Tvardovskiy, K. Wrzesinski, S. Sidoli, S.J. Fey, A. Rogowska-Wrzesinska, O.N. Jensen
          Molecular and Cellular Proteomics 14(12):3142-53; 2015. 
          PMID: 26424599 
          DOI: 10.1074/mcp.M115.048975
          The cultural divide: exponential growth in classical 2D and metabolic equilibrium in 3D environments.
          K. Wrzesinski, A. Rogowska-Wrzesinska, R. Kanlaya, K. Borkowski, V. Schw?mmle, J. Daia, K.E. Joensen, K. Wojdyla, V. Botelho Carvalho & S.J. Fey 
          PLOS One 9(9) 1-15; 2014
          PMID: 25222612 
          DOI: 10.1371/journal.pone.0106973 The cultural divide: exponential growth in classical 2D and metabolic equilibrium in 3D environments.
          K. Wrzesinski, A. Rogowska-Wrzesinska, K. Borkowski, V. Botelho Carvalho & S.J. Fey 
          Poster at 9th Danish Conference on Biotechnology and Molecular Biology, Vejle; 2014 
          DOI: 10.13140/2.1.2643.2965
        7. Heteromer s – using internal standards to assess the quality of proteomic data.
          A. Rogowska-Wrzesinska, K. Wrzesinski and S.J. Fey
          Proteomics. 14(9):1042-7 2014
          PMID: 24616253 
          DOI: 10.1002/pmic.201300457
        8. Microgravity spheroids as a reliable, long term tool for predictive toxicology. 
          S.J. Fey and K. Wrzesinski
          Toxicology Letters, 221S S153 2013. 
          DOI: 10.1016/j.toxlet.2013.05.318
        9. Determination of acute lethal and chronic lethal dose thresholds of Valproic acid using 3D spheroids constructed from the immortal human hepatocyte cell line HepG2/C3A. 
          S.J. Fey and K. Wrzesinski
          In ''Valproic Acid: Pharmacology, Mechanisms of Action and Clinical Implications'' Nova Science Publishers, New York. Ch. V, 141-165; 2013
        10. Human liver spheroids exhibit stable physiological functionality for at least 24 days after recovering from trypsinisation.
          K. Wrzesinski, C.M. Magnone, L. Visby Hansen, M. Ehrhorn Kruse, T. Begauer, M. Bobadilla, M. Gubler, J. Mizrahi, C. M?ller Andreasen, K. Zhang, K. Eyed Joensen, S.M. Andersen and S.J. Fey
          Toxicology Research; 2(3) 163-172; 2013 
          DOI: 10.1039/C3TX20086H 
          NB: Manuscript featured on the front cover of the journal.
        11. After trypsinisation, 3D spheroids of C3A hepatocytes need 18 days to re-establish similar levels of key physiological functions to those seen in the liver.
          K. Wrzesinski and S.J. Fey
          Toxicology Research; 2(2) 123-135; 2013 
          DOI: 10.1039/C2TX20060K
          NB: Manuscript featured on the front cover of the journal.
        12. Determination of drug toxicity using 3D spheroids constructed from immortalized human hepatocytes. 
          S.J. Fey and K. Wrzesinski
          Toxicological Sciences 127(2) 403-411; 2012. 
          PMID: 22454432 
          DOI: 10.1093/toxsci/kfs122


        <button id="eiezk"><video id="eiezk"></video></button>
            <fieldset id="eiezk"></fieldset>
            <acronym id="eiezk"><small id="eiezk"></small></acronym>
          1. <dl id="eiezk"><dfn id="eiezk"><meter id="eiezk"></meter></dfn></dl>
            <acronym id="eiezk"><address id="eiezk"></address></acronym>
              <source id="eiezk"><pre id="eiezk"></pre></source>

              日韩人妻无码精品视频,xxxx日本高清18,色天堂在线观看 | 免费操屄在线视频,国产丝袜精品视频,大香伊人蕉 | 黄片没毛免费的,久久综合久久鬼色,亚洲日韩在线免费观看 | 黄片免费网址,国产丝袜91久久久久久久久久久,人人妻人人爽人人噪 | 26∪u∪成人网站,91看片黄,欧美操逼一级精 | 婷婷视频,娇h女嗯啊黑壮汉好猛hhh视频,国产剧情一区 | 老女人爽视频,午夜视频在线观看91,日韩七区 | 久一久一做一爱一视频,欧美黄页网站,AV午夜剧场 | 国产黄色操逼,国产精品美女网站,成人午夜精品无码区久久中文 | 国产精品1234,扒开美女狂揉下部漫画,特级西西裸体444Www高清大胆 |